CDKN2A and melanoma: This analysis highlighted the value of singular p16 immunohistochemical absence as a predictor for aggressive biological behavior and unfavorable prognosis in familial and/or multiple primary melanomas, in comparison with the exclusive loss of p14, indifferent to the histopathological subtype.